Subject: Final hours...
Final hours...
December 31st, 2018 at 2:49 pm EDTThis is the LAST reminder about BioInformant's New Year’s deal. If you’ve been thinking ...
Happy holidays! 20% off sitewide
December 21st, 2018 at 1:55 pm EDTDear colleague, With the holidays upon us, BioInformant is running its biggest sale of the y ...
Agenda preview enclosed for CAR-T Congress USA
December 13th, 2018 at 9:56 am EDTJoin the 4th annual CAR-T Congress in Boston, April 16- 17 to discover how to overcome the key challenges to Dear colleague, As 2018 draws to a close and long awaited large scale clinical trial data surfaces, ...
Stem cells, cell therapy, and regenerative medicine
November 21st, 2018 at 3:34 pm EDTBIOINFORMANT - 10-31-2018 ...
Regenerative medicine (RM) companies are rapidly populating
October 29th, 2018 at 4:08 pm EDTIntroducing the world’s only searchable, sortable database of regenerative medicine compan ...
CAR-T therapy, breakthrough of the year, agenda now released for Europe congress
October 16th, 2018 at 9:56 am EDTAgenda released for CAR-T Congress Europe 2019Dear colleague, CAR-T cell immunotherapy is at the forefront of innovative cancer therapeutics, with leaps in progress over the past y ...
Pluripotent stem cells, CAR-T, cord blood and more
October 11th, 2018 at 3:51 pm EDTCopy of BIOINFORMANT 9-15-2018 Newsletter ...
CAR-T, iPS cells, perinatal products and more
October 4th, 2018 at 4:09 pm EDTCopy of BIOINFORMANT 9-15-2018 Newsletter ...
I'm sorry
June 27th, 2018 at 2:14 pm EDTI'm sorry! I sent out an offer earlier today that was confusing, so here is a quick clarification. For the next 48 hours, when you claim the “CAR-T Funding Brief” for $49 at this link, you will also ...
Survey results are in...
June 1st, 2018 at 2:39 pm EDTBioInformant has released a 21-page, 50+ respondent survey in which cell therapy manufacturin ...